All Stories

  1. Clinical and epidemiological profile of oral squamous cell carcinoma in young adults: a multicentric study in Argentina
  2. Severity of Betel Quid Use Disorders (BUD) Among Adult Indian Betel Quid Chewers
  3. Cultural Practices and Oral Cancer Risk in the Middle East: A Systematic Review
  4. Oral Dermatoses Map: Key points
  5. Oral Biopsy in General Dental Practice: Procedure, Indications, and Future Perspectives
  6. Betel nut sweets present growing health threat to children
  7. Risk Assessment of Oral Leukoplakia by Individual Dysplasia Features
  8. Optimization of oncological care: proposal for the creation of rehabilitation networks in head and neck oncology
  9. Oral Cancer in the South and South‐East Asia Region, 2022: Incidence and Mortality
  10. Tissue Biomarkers for Predicting the Risk of Oral Cancer in Patients Diagnosed With Oral Leukoplakia: A Systematic Review of the Past 4 Years
  11. Integrating dental and oral care in oncology: a crucial step towards comprehensive cancer treatment
  12. Trends in the Adoption of Terminology for Oral Potentially Malignant Disorders
  13. Mapping tobacco use cessation counselling awareness in dental offices: a cross-country survey
  14. Oral Cancer in Asia
  15. Impact of COVID-19 on the prevalence of oral and maxillofacial disorders: A retrospective cohort study
  16. Primary Care Referral Delays in Oral Cancer Diagnosis: A Meta‐Analysis
  17. Adjunctive aids for the detection of oral squamous cell carcinoma and oral potentially malignant disorders: A systematic review of systematic reviews
  18. Recommendations for Research to Develop a Patient‐Centered Clinical Follow‐Up Protocol for Oral Epithelial Dysplasia
  19. Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis
  20. Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta‐analysis
  21. Isolated lesion of the oral mucosa
  22. Surgical protocols for oral leukoplakia and precancerous lesions across three different anatomic sites
  23. An oral cancer screening program in Brazil: Analysis of seven years of outcome after its implementation in the suburban cities of São Paulo
  24. World Workshop on Oral Medicine VIII: barriers to research in oral medicine: lessons learned from a bibliometric analysis of the oral potentially malignant disorders literature
  25. Differences among oral carcinomas arising de novo from those associated with oral potentially malignant disorders: a systematic review and meta-analysis
  26. Prevalence of human papillomavirus in oral cancer in Asia: A systematic review and meta‐analysis
  27. Professor Emeritus Newell Walter Johnson CMG
  28. Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia – A systematic review
  29. Proliferative verrucous leukoplakia/multifocal leukoplakia in patients with and without oral submucous fibrosis
  30. Oral cancer screening outcomes in the Latin American region with special relevance to Brazil and Cuba: a systematic review
  31. Mucormycosis of the Mandible and Tongue: A Systematic Scoping Review
  32. Difficulty diagnosing oral cancer: seeking an early specialist opinion is key
  33. Reported physical examination methodologies for screening of oral cancer and oral potentially malignant disorders: a systematic review
  34. Clinical and Psychosocial Impact of Communication about Oral Potentially Malignant Disorders: A Scoping Review
  35. Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysis
  36. Management of oral smokeless tobacco keratosis—An opinion
  37. Malignant Transformation of Oral Lichen Planus—An Umbrella Study of Systematic Reviews
  38. World Workshop on Oral Medicine VIII: barriers to Research in Oral Medicine: results from a global survey
  39. An overview of the burden of oral cancer in Sri Lanka and its inequalities in the face of contemporary economic and social malaise
  40. “Textbook outcome” as a quality metric of care in predicting survival from oral cancer
  41. Machine learning for detection and classification of oral potentially malignant disorders: A conceptual review
  42. Carcinogenic Effects of Areca Nut and Its Metabolites: A Review of the Experimental Evidence
  43. The carcinogenicity of opium consumption: a systematic review and meta-analysis
  44. IARC Perspective on Oral Cancer Prevention
  45. Stomatognathic Diseases: State of the Art and Future Perspectives
  46. Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta‐analysis
  47. Comparison of tobacco and alcohol consumption in young and older patients with oral squamous cell carcinoma: a systematic review and meta-analysis
  48. Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews
  49. Chronic mechanical irritation enhances the effect of tobacco and alcohol on the risk of oral squamous cell carcinoma: a case-control study in Argentina
  50. Oral Warty Dyskeratoma—A Systematic Review of the Literature
  51. Areca Nut and Oral Cancer: Evidence from Studies Conducted in Humans
  52. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia
  53. Reexamination of delays in diagnosis of oral cancer following an intervention program in Cordoba, Argentina
  54. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis
  55. Is oral lichen planus potentially malignant: A reply to Yu‐Wei Chiu et al
  56. Autoimmune disorders in oral lichen planus: A systematic review and meta‐analysis
  57. Oral leukoplakia: A clinicopathological study and malignant transformation
  58. Oral potentially malignant disorders: Proceedings from an expert symposium
  59. Prognosis Parameters of Oral Carcinomas Developed in Proliferative Verrucous Leukoplakia: A Systematic Review and Meta-Analysis
  60. Telemedicine contributing to an incidental finding of a premalignant lesion
  61. Assembling a consensus on actinic cheilitis: A Delphi study
  62. Oral Cancer Screening: Past, Present, and Future
  63. Malignant transformation of oral proliferative verrucous leukoplakia: A systematic review and meta‐analysis
  64. Secondhand smoke exposure and oral cancer risk: a systematic review and meta-analysis
  65. Malignant transformation of oral leukoplakia: Systematic review and meta‐analysis of the last 5 years
  66. Evaluation of a social marketing campaign for the early detection of oral potentially malignant disorders and oral cancer: Sri Lankan experience
  67. Oral cancer development in lichen planus and related conditions—3.0 evidence level: A systematic review of systematic reviews
  68. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review
  69. Lichenoid morphology could be an early feature of oral proliferative verrucous leukoplakia
  70. Lichenoid proliferative leukoplakia, lichenoid lesions with evolution to proliferative leukoplakia or a continuum of the same precancerous condition? A revised hypothesis
  71. An appraisal of highest quality studies reporting malignant transformation of oral lichen planus based on a systematic review
  72. Malignant transformation of oral submucous fibrosis: A systematic review and meta‐analysis
  73. 25th anniversary of oral diseases
  74. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer
  75. Carcinogenicity of opium consumption
  76. Oral potentially malignant disorders: A scoping review of prognostic biomarkers
  77. Public health measures to reduce areca nut and betel quid use for control of oral cancer in Taiwan
  78. Prognostic and clinicopathological significance of podoplanin immunoexpression in oral and oropharyngeal squamous cell carcinoma: A systematic review
  79. Protecting dental manpower from COVID‐19 infection
  80. Screening for oral cancer: Future prospects, research and policy development for Asia
  81. Malignant transformation of oral leukoplakia: a follow-up study
  82. Worldwide prevalence of oral lichen planus: A systematic review and meta‐analysis
  83. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management
  84. Prognostic biomarkers in oral leukoplakia
  85. Tobacco related oral cancer
  86. White, red, and mixed lesions of oral mucosa: A clinicopathologic approach to diagnosis
  87. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis
  88. Clinical features and presentation of oral potentially malignant disorders
  89. Betel quid chewing among adult male immigrants from the Indian subcontinent to Italy
  90. The 100 most cited articles on oral cancer
  91. Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas
  92. Human papillomavirus (HPV): making the case for ‘Immunisation for All’
  93. From the laboratory to the bed side
  94. Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis
  95. Oral submucous fibrosis: a review of the current management and possible directions for novel therapies
  96. Interventions for treating oral leukoplakia to prevent oral cancer
  97. Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?
  98. Image-based DNA ploidy analysis aids prediction of malignant transformation in oral lichen planus
  99. Relative Frequency of Oral Malignancies and Oral Precancer in the Biopsy Service of Jazan Province, 2009-2014
  100. Global burden of oral diseases: emerging concepts, management and interplay with systemic health
  101. Is there a relationship between periodontal disease and oral cancer? A systematic review of currently available evidence
  102. Management of oral Graft versus Host Disease with topical agents: A systematic review
  103. Metastases from the lung presenting as a parotid lump
  104. Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions
  105. The pattern of lip cancer occurrence over the 1990–2011 period in public hospitals in Madrid, Spain
  106. Malignant transformation of oral leukoplakia: a systematic review of observational studies
  107. Addictive Behaviours Need to Include Areca Nut Use
  108. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions
  109. The role of patch testing in the management of oral lichenoid reactions
  110. Periodontal Parameters and Whole Salivary Cytokine Profiles Among Habitual Gutka Chewers and Non-Chewers
  111. Oral cancer: Two cancer cases in a career?
  112. Knowledge and attitude of tobacco use and cessation among dental professionals
  113. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders—a clinicopathological evaluation
  114. Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review
  115. Radiographic volume analysis as a novel tool to determine nasopalatine duct cyst dimensions and its association with presenting symptoms and postoperative complications
  116. Available web-based teaching resources for health care professionals on screening for oral cancer
  117. Ectopic Oral Tonsillar Tissue: A Case Series with Bilateral and Solitary Presentations and a Review of the Literature
  118. Screening for oral potentially malignant disorders among areca (betel) nut chewers in Guam and Saipan
  119. An appraisal of oral cancer and pre‐cancer screening programmes in Europe: a systematic review
  120. Lichenoid dysplasia revisited – evidence from a review of Indian archives
  121. Treatment of oral leukoplakia with a low‐dose of beta‐carotene and vitamin C supplements: A randomized controlled trial
  122. The use of light‐based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review
  123. Outcomes of invitational and opportunistic oral cancer screening initiatives in Oporto, Portugal
  124. Betel quid chewing and the risk of oral and oropharyngeal cancers: A meta-analysis with implications for cancer control
  125. Betel-quid dependence domains and syndrome associated with betel-quid ingredients among chewers: an Asian multi-country evidence
  126. Pulsed versus continuous wave CO2 laser excisions of 100 oral fibrous hyperplasias: A randomized controlled clinical and histopathological study
  127. Donald Winstock
  128. Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory
  129. Prognostic and predictive markers for oral squamous cell carcinoma: The importance of clinical, pathological and molecular markers
  130. Evaluation of micronuclear frequencies in both circulating lymphocytes and buccal epithelial cells of patients with oral lichen planus and oral lichenoid contact reactions
  131. Periodontal Inflammatory Conditions Among Gutka Chewers and Non-chewers With and Without Prediabetes
  132. Predictive Value of Dysplasia Grading and DNA Ploidy in Malignant Transformation of Oral Potentially Malignant Disorders
  133. Mutation of keratin 4 gene causing white sponge nevus in a Japanese family
  134. Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma
  135. An assessment of mast cells and myofibroblasts in denture-induced fibrous hyperplasia
  136. Diet and risk of oral potentially malignant disorders in rural Sri Lanka
  137. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions
  138. Betel-quid dependence and oral potentially malignant disorders in six Asian countries
  139. Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal
  140. Curriculum survey on tobacco education in European dental schools
  141. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity - a clinical and histological assessment
  142. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma
  143. Population Burden of Betel Quid Abuse and Its Relation to Oral Premalignant Disorders in South, Southeast, and East Asia: An Asian Betel-Quid Consortium Study
  144. Oral Lichenoid Contact Lesions to Mercury and Dental Amalgam—A Review
  145. Oral Cancer Awareness and Knowledge in the City of Valongo, Portugal
  146. Areca-nut chewing habit is a significant risk factor for metabolic syndrome: A systematic review
  147. Copy Number and Loss of Heterozygosity Detected by SNP Array of Formalin-Fixed Tissues Using Whole-Genome Amplification
  148. Squamous cell carcinoma and precursor lesions: prevention
  149. Declining oral cancer rates in Sri Lanka: are we winning the war after being at the top of the cancer league table?
  150. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England
  151. Waterpipe smoking, oral cancer and other oral health effects
  152. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses
  153. Global Oral Health Inequalities in Incidence and Outcomes for Oral Cancer
  154. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses
  155. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions
  156. Rituximab for the treatment of corticosteroid - refractory pemphigus vulgaris with oral and skin manifestations
  157. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities
  158. Intercountry prevalences and practices of betel‐quid use in south, southeast and eastern asia regions and associated oral preneoplastic disorders: An international collaborative study by asian betel‐quid consortium of south and east Asia
  159. Screening for oral cancer: contributing to the debate
  160. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus
  161. How well informed are our Internet savvy patients on oral premalignant disorders?
  162. Public awareness of oral cancer, of oral potentially malignant disorders and of their risk factors in some rural populations in Sri Lanka
  163. Is workplace screening for potentially malignant oral disorders feasible in India?
  164. Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence
  165. Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival
  166. Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay?
  167. The experiences of young oral cancer patients in Scotland: symptom recognition and delays in seeking professional help
  168. Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: A case-control study
  169. Maté drinking and oral and oro-pharyngeal cancer: A systematic review and meta-analysis
  170. Relationship between mercury levels in blood and urine and complaints of chronic mercury toxicity from amalgam restorations
  171. Knowledge of oral cancer and preventive attitudes of Spanish dentists. Primary effects of a pilot educational intervention
  172. Angioleiomyoma: An unusual diagnosis for a lump in the cheek
  173. Causes of oral cancer – an appraisal of controversies
  174. Molecular markers in oral epithelial dysplasia: review
  175. Micronuclear and sister chromatid exchange analyses in peripheral lymphocytes of patients with oral lichen planus – a pilot study*
  176. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study
  177. P1.116. Evaluation of diagnostic aids for the detection of oral potentially malignant disorders
  178. p53 mutations in keratocystic odontogenic tumour
  179. Global epidemiology of oral and oropharyngeal cancer
  180. Prognostic factors for keratocystic odontogenic tumor (odontogenic keratocyst): analysis of clinico‐pathologic and immunohistochemical findings in cysts treated by enucleation
  181. Significant oral cancer risk associated with low socioeconomic status
  182. Food, nutrition and oral cancer
  183. Orofacial presentations of sarcoidosis – a case series and review of the literature
  184. Cell biology of the periodontiurn in health and disease
  185. Journal policy
  186. Oral health in Asia
  187. Demonstration of ethanol‐induced protein adducts in oral leukoplakia (pre‐cancer) and cancer
  188. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement
  189. Oral cancer survival in young people in South East England
  190. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users
  191. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment
  192. Interventions for the treatment of oral and oropharyngeal cancers: immunotherapy/biotherapy
  193. Oral cancer and precancer prevalence in a high risk Sri Lankan group
  194. Nomenclature and classification of potentially malignant disorders of the oral mucosa
  195. Development of an in vivo mouse model to study oral submucous fibrosis
  196. Management of oral epithelial dysplasia: a review
  197. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations
  198. Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco – a review
  199. The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit
  200. Oral cancer: experiences and diagnostic abilities elicited by dentists in North‐western Spain
  201. Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999)—recent trends and regional variation
  202. Oral submucous fibrosis: Review on aetiology and pathogenesis
  203. Effect of areca nut on salivary copper concentration in chronic chewers
  204. Tobacco cessation activities of UK dentists in primary care: Signs of improvement
  205. Effective management of smoking in an oral dysplasia clinic in London
  206. Incidence rates for oral leukoplakia and lichen planus in a Japanese population
  207. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan
  208. Bidi smokers at increased risk of oral cancer
  209. Letters to the Editor from Axéll, Zatterstrom, and Warnakulasuriya
  210. Tobacco, oral cancer, and treatment of dependence
  211. A survey on the uses of acupuncture by a group of UK dentists
  212. Aplasia of submandibular salivary glands associated with ectodermal dysplasia
  213. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case–control study in Southern England
  214. Factors associated with delay in presentation among younger patients with oral cancer
  215. Prevalence of oral mucosal lesions in alcohol misusers in south London
  216. An analysis of risk factors for oral cancer in young people: a case-control study
  217. Smokeless tobacco and oral cancer
  218. Amiodarone‐induced peri‐oral photosensitivity
  219. Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki‐67 index
  220. Multiple primary tumours following head and neck cancer in southern England during 1961–98
  221. The impact of stomatological disease on oral health‐related quality of life
  222. Neoplasia of the tongue in a patient with Crohn's disease treated with azathioprine
  223. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997
  224. Annual screening for oral cancer detection
  225. Epithelial cell proliferation in oral lichen planus
  226. Fluoride content of alcoholic beverages
  227. Oral manifestations of an HIV positive cohort in the era of highly active anti‐retroviral therapy (HAART) in South London
  228. Areca nut use following migration and its consequences
  229. Chemical and analytical aspects of areca nut
  230. Global epidemiology of areca nut usage
  231. Introduction: Biology, medical and socio-economic aspects of areca nut use
  232. The oral health consequences of chewing areca nut
  233. Editors’ editorial
  234. Risk factors for squamous cell carcinoma of the oral cavity in young people — a comprehensive literature review
  235. Serum antioxidant micronutrient levels in oral lichen planus
  236. Betel quid chewing among Bangladeshi adolescents living in East London
  237. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan
  238. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese
  239. Outcome following a population screening programme for oral cancer and precancer in Japan
  240. Raised tissue copper levels in oral submucous fibrosis
  241. Predictors of tobacco and alcohol consumption and their relevance to oral cancer control amongst people from minority ethnic communities in the South Thames health region, England
  242. A dependency syndrome related to areca nut use: some medical and psychological aspects among areca nut users in the Gujarat community in the UK
  243. Cancer of mouth, pharynx and nasopharynx in Asian and Chinese immigrants resident in Thames regions
  244. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
  245. Toombak Use and Cigarette Smoking in the Sudan: Estimates of Prevalence in the Nile State
  246. Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancer
  247. Management of potentially malignant oral mucosal lesions by consultant UK oral and maxillofacial surgeons
  248. The influence of rate of cell entry to S phase on the labelling index of human buccal epithelium
  249. Diurnal variation in labelling index in human buccal epithelium
  250. Apparent deterioration in dental care of 12 year olds in north London'
  251. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing
  252. Trends in the incidence of oral carcinoma in Northern Ireland 1975–89'
  253. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
  254. Investigating a lingual thyroid
  255. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases
  256. Compliance following referral in the early detection of oral cancer and precancer in Sri Lanka
  257. Impression material presenting in the maxillary antrum as a foreign body
  258. Demand for dental care in Sri Lanka
  259. Familial hyperparathyroidism associated with cementifying fibromas of the jaws in two siblings
  260. Oral mucosal changes in iron deficiency anemia in a Sri Lankan female population